Dechra Pharmaceuticals PLC Director Declaration (8560Z)

TIDMDPH

RNS Number : 8560Z

Dechra Pharmaceuticals PLC

17 March 2017

Dechra(R) Pharmaceuticals PLC

("Dechra" or "the Company")

Director's Declaration

In accordance with Listing Rule 9.6.14(2) Dechra announces that Ishbel Macpherson, Non-Executive Director of Dechra, is to be appointed as a

Non-Executive Director of Fidessa group plc with effect from 1 May 2017.

For further information:

Suzana Cross, Company Secretary and General Counsel

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Its expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNBUGDXUBBBGRR

(END) Dow Jones Newswires

March 17, 2017 11:17 ET (15:17 GMT)

Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024